comparemela.com

Latest Breaking News On - க்ரேல் - Page 2 : comparemela.com

EU to examine Illumina s $7 1 billion acquisition of Grail on antitrust grounds

2 Min Read FILE PHOTO: The offices of gene sequencing company Illumina Inc are shown in San Diego, California January 11, 2016. REUTERS/Mike Blake BRUSSELS (Reuters) - EU antitrust regulators will examine Illumina Inc’s proposed $7.1 billion acquisition of cancer test maker Grail Inc, the European Commission said on Tuesday, following a request from six countries on competition concerns. U.S. life sciences company Illumina announced last September that it would acquire Grail - which it previously owned before spinning it off as a separate business four years ago - by buying out investors including Amazon.com Inc founder Jeff Bezos. Illumina had remained the company’s largest shareholder.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.